David Elsley
Förmögenhet: 1 M $ per 2026-06-30
Förmögenhet: 1 M $ per 2026-06-30
David G.
Elsley was the founder of Vasogen, Inc., founded in 1990, where the title held was Director from 1990 to 2009.
Mr. Elsley is the founder of Cardiol Therapeutics, Inc., founded in 2017, holding the titles of President, Chief Executive Officer & Director since 2017.
Mr. Elsley completed an MBA degree at Richard Ivey School of Business.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-12-30 | 1 344 500 ( 1,17 % ) | 1 M $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| CARDIOL THERAPEUTICS INC. | Grundare | 2017-01-19 |
| Företag | Position | Slut |
|---|---|---|
Vasogen, Inc.
Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Grundare | 2009-10-23 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Vasogen, Inc.
Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Health Technology |
Richard Ivey School of Business
Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiol Therapeutics, Inc.
Cardiol Therapeutics, Inc. BiotechnologyHealth Technology Operates as a life sciences company that researches and develops antifibrotic and anti-inflammatory therapy for the treatment of cardiovascular disease | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån